JMKX003948 Ophthalmic Suspension

· Jemincare

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JMKX003948 Ophthalmic Suspension, covering 2025-02-18 to 2025-02-18. Get the full timeline:

Most recent: Clinical Trial Update: Study of JMKX003948 Ophthalmic Suspension in Healthy Participants [Phase 1]